Luteinizing hormone releasing hormone analogues in the treatment of patients with prostate cancer
Prostate cancer (PC) is the most pressing oncourological pathology due to a steady increase in morbidity and mortality from this pathology in the Russian Federation.The detection frequency of the common forms of the disease remains high.The combined chemo-hormonal therapy is the main method of treatment of metastatic prostate cancer.The refractorin